OBJECTIVES: To develop models of 30-day mortality and cardiopulmonary morbidity from data on anatomic lung resections deposited in the European Society of Thoracic Surgeons (ESTS) database.
INTRODUCTION
Risk-adjusted outcome analysis is critical for monitoring surgical performance and implementing measures to improve quality of care. The European Society of Thoracic Surgeons (ESTS) has recently established an institutional accreditation program to standardize and improve practice across institutions in Europe according to existing guidelines. The main instrument for this process is the calculation of a composite performance score incorporating process and outcome indicators. The outcome indicators include risk-adjusted morbidity and risk-adjusted mortality. The most recent risk-adjusted models were developed several years ago [1, 2] and are based on a population of approximately 4000 patients extracted from the ESTS database. The ESTS database has continued to grow in the last several years and currently includes 48 000 anatomic lung resections.
The objective of this analysis is to develop new, updated models of in-hospital or 30-day cardiopulmonary mortality and morbidity rates to be used in future quality-of-care initiatives and as a reliable instrument of risk stratification during patient counselling before surgery.
PATIENTS AND METHODS
This study is a retrospective analysis of 47 960 anatomic lung resections registered in the ESTS database from July 2007 to August 2015 (36 376 lobectomies, 2296 bilobectomies, 5040 pneumonectomies and 4248 segmentectomies). Patients who had non-anatomic lung resections (wedge) or for whom data on mortality or complication rates were incomplete were excluded from the analysis.
The ESTS database is a voluntary general thoracic surgery database that was launched on line in July 2007 and is free to all ESTS members. Surgeons can input their data on line or import their own data set on a yearly basis through an automated procedure that involves variable matching. The database comprises data and information from more than 200 European institutions.
All variables in the database have been defined a priori. Definitions of variables and outcomes (including morbidity) are detailed in the recent joint STS-ESTS paper on standardization of definition of variables in the respective registries [3] . Only a minor portion of data in the ESTS database is audited, in particular, the data for those units that participate in the ESTS Institutional Accreditation program.
Statistical analysis
The following cardiopulmonary complications listed in the ESTS database were included in the outcome variables: respiratory failure, need for reintubation, prolonged mechanical ventilation >24 h, pneumonia, atelectasis requiring bronchoscopy, pulmonary oedema, pulmonary embolism, acute respiratory distress syndrome/acute lung injury, arrhythmia requiring treatment, acute myocardial ischemia, acute cardiac failure, stroke/transient ischaemic attacks and acute kidney injury.
Mortality is defined as death in-hospital or within 30 days from operation if the patient was discharged.
Several baseline and surgical variables were tested for a possible association with morbidity or mortality. The normal distribution of numerical variables was first assessed by the ShapiroWilk normality test.
An initial screening of variables was performed before applying logistic regression analysis to develop the models. The variables were screened by univariable analysis, and only those with a P < 0.05 were used as independent predictors in the logistic regression model. Numerical variables with normal distribution were tested using the unpaired Student's t-test, whereas those without normal distribution were tested using the MannWhitney U test. Categorical variables were tested using the v 2 test or the Fisher's exact test as appropriate.
Numerical variables with normal distribution were tested by the unpaired Student's t-test whereas those without normal distribution were tested by the Mann-Whitney U test. Categorical variables were tested by the v 2 test. The following variables were initially analysed: age, sex, body mass index (BMI), American Society of Anaesthesiologists (ASA) score, predicted postoperative forced expiratory volume in 1 s (ppoFEV1), predicted postoperative carbon monoxide lung diffusion capacity (ppoDLCO), coronary artery disease (CAD), cerebrovascular disease (CVD), diabetes, chronic kidney disease (CKD), type of operation (pneumonectomy vs lobectomy/segmentectomy), type of surgical approach [video-assisted thoracoscopic surgery (VATS) vs open], extended resection (associated with chest wall, Pancoast tumours, resection of the atrium or superior vena cava, diaphragm resection, vertebral resection, pleuropneumonectomy, sleeve pneumonectomies, intrapericardial pneumonectomy) and induction therapy.
Predicted postoperative FEV1 or DLCO was calculated in a standardized way by inputting into the database the number of functioning/ventilating segments removed during the operation.
Missing variables were imputed by averaging the non-missing numerical ones or by choosing the most frequent of the categorical variables. Variables for which more than 10% of the data were missing were not used for the analysis.
ppoDLCO was available for only 14 089 patients (29%); for this reason it was not used for developing the models.
Significant variables at univariable analysis were used as independent predictors in the stepwise logistic regression analysis. Two separate models were developed, one for cardiopulmonary morbidity and the other for cardiopulmonary mortality.
Stepwise regression with backward elimination of variables was used.
Linearity assumption was checked with graphical plotting of logit log-linear regression.
Variables with a P-value <0.05 were retained in the model and validated with bootstrap resampling analysis using 1000 bootstrap simulated samples of the same number of observations as the original data set (47 960 patients). Only those variables that were significant (P < 0.05) in more than 80% of the samples were included in the final model [4] [5] [6] .
Bootstrapping is a technique of resampling with replacement through which new samples (typically 1000) of patients are generated by randomly selecting individuals from the original database.
At each step of the simulation, each individual from the original database is again eligible to be selected, irrespective of whether he or she has already been sampled. Therefore, in each bootstrap sample, some of the original individuals may not be represented and others may be represented more than once. We have previously shown that the use of the entire data set to develop the risk model and the use of bootstrapping for its internal validation were superior to the traditional training and testing method of randomly splitting the database in a development and a validation set. When applied to an external population, the model developed using the entire database and validated by bootstrapping performed better than several models obtained by the training and testing methods [6] . For this reason, we chose to use the former approach in this analysis.
The variables that were significant on logistic regression were used to construct an aggregate model according to the methods described in previous studies [7, 8] . To this purpose, a threshold effect was searched for numerical variables using ROC analysis, and numerical variables were categorized on the basis of the best cut-off value.
A score was assigned to each variable in the model by proportionally weighting the regression coefficients and assigning 1 point to the smallest one. A total score was generated for each patient by adding the individual points assigned to each variable. The patients were finally grouped together in risk classes according to their scores and a similar incidence of morbidity or mortality within the group.
All tests were performed using Stata 12.0 statistical software (Stata Corp., College Station, TX, USA).
RESULTS
The characteristics of the patients included in the analysis are shown in Table 1 . Major cardiopulmonary complications occurred in 8805 patients (18.4%) and 1295 patients died inhospital or within 30 days after the operation (2.7%). The mortality rate was 6.8% after pneumonectomy, 2.3% after lobectomy/ bilobectomy and 1.4% after segmentectomy. A total of 18.3% of pneumonectomies were classed as extended versus 4.1% of lobectomies. Overall, 2548 anatomic resections were extended operations with a mortality rate of 5.3% vs 2.5% in non-extended operations (P < 0.0001).
Analysis of morbidity
The following numerical variables were significantly associated with morbidity after univariable analysis age: ppoFEV1 and ASA. ppoDLCO was available in only 14 089 and was significantly lower in complicated patients ( Table 2) .
The following categorical variables were associated with morbidity: sex, pneumonectomy, extended resections, diabetes, CAD, induction therapy, CKD, CVD and thoracotomy approach ( Table 2) . Table 3 shows the results of the stepwise logistic regression analysis (dependent variable: cardiopulmonary morbidity; Hosmer-Lemeshow goodness of fit statistics P = 0.4, C-index 0.68).
The following variables resulted independently and were reliably associated with morbidity: sex (P < 0.0001), age (P < 0.0001), ppoFEV1 (P < 0.0001), CAD (P < 0.0001), CVD (P < 0.0001), CKD (P < 0.0001), thoracotomy approach (P < 0.0001) and extended resections (P < 0.0001). All variables had a significant bootstrap frequency greater than 95%, indicating very high stability and reproducibility.
The following logistic morbidity model was generated (Logistic EuroLung1): logit (morbidity) = -2.465 + 0.497Xsex male (coded 1 for male and 0 for female) + 0.026Xage + 0.231XCAD (coded 1 for presence of CAD) + 0.371XCVD (coded 1 for presence of CVD) + 0.152XCKD (coded 1 for presence of CKD) -0.015XppoFEV1 + 0.514X extended resections (coded 1 for presence of extended resection) + 0.497Xthoracotomy (coded 1 for thoracotomy and 0 for VATS). Figure 1A shows the predicted morbidity plotted against the observed morbidity with the patients ordered by increasing risk of morbidity according to EuroLung1. The two lines almost overlap, indicating the high precision of the model. ROC analysis was then used to categorize numerical variables in order to construct the aggregate risk model; the best cut-off values for ppoFEV1 and age were 70% and 65 years, respectively.
Logistic regression was repeated including age and ppoFEV1 as categorical variables according to these cut-off values.
Aggregate risk score (Aggregate EuroLung1) was developed based on proportional weighting of the coefficients, assigning 1 point to the lowest coefficient (CKD):
CKD, 1 point; CAD and CVD2, 2 points; age > 65, sex male, thoracotomy, extended resections and ppoFEV1 < 70%, 3 points. The points were summed for each patient to generate an aggregate score.
Total individual scores varied from 0 to 19 points. Patients with scores associated with similar risk of morbidity were then grouped in six classes of incremental morbidity risk ( Table 4) . The difference in morbidity between these classes was significant (P < 0.0001). 
Analysis of mortality
Univariable analysis showed that the following variables were associated with mortality: age, ppoFEV1, BMI, ASA and ppoDLCO (present in only 14 089 patients). Sex, CAD, CVD, pneumonectomy, thoracotomy approach and extended resections were also associated with increased risk of mortality (Table 5) . Table 6 shows the results of the stepwise logistic regression analysis (dependent variable: in-hospital or 30-day mortality; HosmerLemeshow goodness of fit statistics P = 0.2, C-index 0.74).
The following variables resulted independently and were reliably associated with mortality: sex male (P < 0.0001), age (P < 0.0001), ppoFEV1 (P < 0.0001), CAD (P = 0.003), CVD (P < 0.0001), BMI (P < 0.0001), thoracotomy approach (P < 0.0001), pneumonectomy (P < 0.0001) and extended resections (P = 0.002). All variables had a significant bootstrap frequency greater than 80%, indicating very high stability and reproducibility.
The following logistic mortality model was generated (Logistic EuroLung2): logit (mortality) = -5.82 + 0.903Xsex male (coded 1 for male and 0 for female) + 0.044Xage + 0.264XCAD (coded 1 for presence of CAD) + 0.582XCVD (coded 1 for presence of CVD) -0.064XBMI + 0.300Xextended resection (coded 1 for extended resection) + 0.929X pneumonectomy (coded 1 for pneumonectomy and 0 for lesser resection) + 0.894Xthoracotomy (coded 1 for thoracotomy and 0 for VATS) -0.009XppoFEV1. Figure 1B shows the predicted mortality rate plotted against the observed mortality rate with the patients ordered by increasing risk of mortality according to EuroLung2. The two lines almost overlap, indicating the high precision of the model. ROC analysis was then used for categorizing numerical variables in order to construct the aggregate risk model. The best cut-off values for ppoFEV1, age and BMI were 70%, 65 years and 18.5 kg/m 2 . The regression analysis was then repeated including age, ppoFEV1 and BMI as categorical variables according to the above-mentioned cut-off values.
An aggregate risk score was developed based on proportional weighting of the coefficients, assigning 1 point to the lowest coefficient (Aggregate EuroLung2): ppoFEV1 < 70%, CAD and extended resections 1 point; age > 65 and CVD, 2 points; sex, thoracotomy, BMI < 18.5 and pneumonectomy, 3 points.
The points were summed for each patient to generate an aggregate score.
The total individual scores varied from 0 to 17 points. Patients with scores associated with similar risk of mortality were then grouped in six classes of incremental risk of mortality ( Table 7) . The difference in mortality rates between these classes was significant (P < 0.0001).
DISCUSSION

Background and objective
Risk-adjusted models of morbidity and mortality are fundamental components of quality-of-care metrics. As an example, a few years ago, the ESTS developed a composite performance score incorporating process and outcome indicators to evaluate the quality of surgical care of units practicing in Europe with the intent to provide a feedback instrument to improve and standardize performance across the continent according to existing evidence. When they are used as quality indicators, outcome end-points need to be reliable and adjusted to the case mix of the population in which they are applied to minimize risk aversion attitudes. In addition, although risk models should not be Results are expressed as means (standard deviations unless otherwise specified). BMI: body mass index; ppoFEV1: predicted postoperative forced expiratory volume in 1 s; CAD: coronary artery disease; CVD: cerebrovascular disease; CKD: chronic kidney disease; ASA: American Society of Anaesthesiologists. used to select patients for operation on an individual basis, they can be used as a tool during the shared decision-making process to provide an estimate of the surgical risk for specific classes of patients with certain characteristics. For all of the arguments mentioned above, the risk models must be reliable and based on large populations representative of our specialty. Several years ago, the ESTS database committee published risk models for in-hospital mortality [9] and then for both morbidity and mortality [1] . Those models were generated from analyses performed on just a few thousand patients registered in the ESTS database.
The ESTS database comprises more than 48 000 anatomic lung resections, a sample size more than 10-fold larger than the one used to develop previous models. In addition, the adoption of new techniques such as video-assisted thoracoscopy warrants an update of the old models in order to be more representative of modern thoracic surgery practice in Europe. Therefore, the objective of this analysis is to develop new, large population-based risk-adjusted models of cardiopulmonary morbidity and 30-day mortality rates following anatomic lung resections.
Main findings
We were able to generate two separate risk models for cardiopulmonary morbidity and 30-day mortality rates from a large database including more than 48 000 anatomic lung resections.
The two risk models contain 8 and 9 variables, respectively. They are therefore less parsimonious than the previously published ESTS models [1, 9] , but more parsimonious than the recently updated corresponding Society of Thoracic Surgeons risk models [10] , which include 15 to 17 variables each.
Another similar model for mortality was developed from more than 18 000 patients registered in Epithor, the French Thoracic Surgery database [11] . The model, which represents a refinement of the original and less specific Thoracoscore [12] , comprised 11 variables; its discrimination according to the C-index analysis was 0.78.
All variables included in the two models showed a high degree of stability when tested on multiple bootstrap models; only those with a bootstrap frequency above 80% were retained in the final models to ensure reproducibility and reliability.
Variables common to both models (morbidity and mortality) were male sex, age, ppoFEV1, CAD, CVD, thoracotomy approach instead of VATS and extended resection.
CKD was more specific for morbidity whereas BMI and pneumonectomy were predictive only of mortality.
Some of these factors are well-known risk factors included in previous risk models. In previous models from ESTS and those used thus far in the composite performance score, ppoFEV1, cardiac disease and pneumonectomy were common risk factors for both morbidity and mortality [1] .
In the recently updated STS risk models, older age, male sex, FEV1, BMI, CAD, CVD, extent of resection and thoracotomy approach were also factors associated with mortality [10] .
The similarity of risk factors in both the European and North American models confirms their reliability across different populations. Nevertheless, the C statistics of the morbidity models were 0.68 in both continental data sets, whereas those of the mortality models showed slightly better discrimination ability compared to the morbidity models (0.78 in the STS model vs 0.74 in the ESTS model). The levels of the C statistics are in line with the most commonly reported discrimination ability of risk models in our specialty, indicating only a moderate prediction at best. Especially when using large organizational databases, there may be unknown or unaccounted for variables with a potential association with outcome that were not captured and computed into the analysis.
In an attempt to provide a simple instrument of risk assessment during surgical consultation, in addition to the regression equations, we generated two aggregate scores incorporating the above-mentioned significant risk factors weighted according to their regression coefficients. In this way, we created two risk scores containing six classes of risk each.
The risk scores appear to stratify the individual risk well. For instance, the risk of mortality in a patient in the lowest class of risk was 0.4 vs 29.4% for a patient in the highest class of risk.
Limitations
This work may have the following potential limitations:
• First, it has the inherent selection bias of all retrospective analyses. Patients in the different units may have been selected for surgery using variable criteria, which have an effect on the model. • A second problem may lay in the use of morbidity as an outcome. Although the variable has been defined according to standardized criteria [3] , it may be subject to entry error, miscoding or under-reporting. In addition, morbidity was not weighted, because a grading system (i.e. TMM) was not present in the ESTS database at the time of data analysis.
• Third, some important variables have not been included in the model for under-representation. For instance, DLCO was only present in fewer than 30% of patients and could not be used to develop the models. Similarly, maximum oxygen consumption (VO 2max ), which is another known predictor of complications, was only present in 6% of patients and was not included in the model. These missing data reflect the selective measurement of these parameters rather than a real missing entry (data not present and not entered). The inclusion of these and other missing or unknown variables may contribute in the future to improved model performance.
• Fourth, deaths were limited to 30-day or in-hospital. The ESTS database does not collect 90-day mortality or longer term survival data, which would be interesting information to include in a future model. • Fifth, the ESTS database captures only a fraction of the thoracic activity in Europe. It is estimated that fewer than 20% of all general thoracic surgery departments in Europe register their data in the database. The models developed from the population registered in the database may therefore not be entirely representative of the real practice in Europe.
• Finally, the quality of variables present in the database affects the risk model analysis. Previous investigation has shown that the quality of the variables in the ESTS database is generally high [13, 14] . It must be noted, however, that only a small fraction of the data in the database is audited. The results should be therefore interpreted taking this limitation into account.
Clinical implications
The models developed from the current analysis will be incorporated in the upcoming version of the composite performance score and used as a fundamental part of the European Institutional Accreditation Program. The models, expressed as aggregate scores, represent a simple instrument of risk assessment. Although these risk scores should not be used to select patients for operation, they can help to identify those patients who need further assessment during the preoperative consultation. These scores will help the surgeon to more clearly define the patient's surgical risk and optimize his or her medical condition before surgery. In addition, these scores may be used as tools during the surgical consultation to inform the shared decision-making process.
Finally, the aggregate scores may be used as selection criteria to enrol high-risk classes of patients in trials designed to investigate alternative surgical or non-surgical treatments (e.g. sublobar resections and stereotactic body radiation therapy).
